Follow-up to Adolescence after Early Peanut Introduction for Allergy Prevention
Authors:
Top Cited Papers
- 28 May 2024
- journal article
- research article
- Published by Massachusetts Medical Society in NEJM Evidence
- Vol. 3 (6)
Abstract
A randomized trial demonstrated consumption of peanut from infancy to age 5 years prevented the development of peanut allergy. An extension of that trial demonstrated the effect persisted after 1 year of peanut avoidance. This follow-up trial examined the durability of peanut tolerance at age 144 months after years of ad libitum peanut consumption. Participants from a randomized peanut consumption trial were assessed for peanut allergy following an extended period of eating or avoiding peanuts as desired. The primary end point was the rate of peanut allergy at age 144 months. We enrolled 508 of the original 640 participants (79.4%); 497 had complete primary end point data. At age 144 months, peanut allergy remained significantly more prevalent in participants in the original peanut avoidance group than in the original peanut consumption group (15.4% [38 of 246 participants] vs. 4.4% [11 of 251 participants]; P<0.001). Participants in both groups reported avoiding peanuts for prolonged periods of time between 72 and 144 months. Participants at 144 months in the peanut consumption group had levels of Ara h2-specific immunoglobulin E (a peanut allergen associated with anaphylaxis) of 0.03 ± 3.42 kU/l and levels of peanut-specific immunoglobulin G4 of 535.5 ± 4.98 μg/l, whereas participants in the peanut avoidance group had levels of Ara h2-specific immunoglobulin E of 0.06 ± 11.21 kU/l and levels of peanut-specific immunoglobulin G4 of 209.3 ± 3.84 μg/l. Adverse events were uncommon, and the majority were related to the food challenge. Peanut consumption, starting in infancy and continuing to age 5 years, provided lasting tolerance to peanut into adolescence irrespective of subsequent peanut consumption, demonstrating that long-term prevention and tolerance can be achieved in food allergy. (Funded by the National Institute of Allergy and Infectious Diseases and others; ITN070AD, ClinicalTrials.gov number, NCT03546413.).Keywords
This publication has 35 references indexed in Scilit:
- The natural history of peanut and egg allergy in children up to age 6 years in the HealthNuts population-based longitudinal studyJournal of Allergy and Clinical Immunology, 2022
- Prevalence and characteristics of peanut allergy in US adultsJournal of Allergy and Clinical Immunology, 2021
- The prevalence of food allergy and other allergic diseases in early childhood in a population-based study: HealthNuts age 4-year follow-upJournal of Allergy and Clinical Immunology, 2017
- Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panelJournal of Allergy and Clinical Immunology, 2017
- Impact of peanut consumption in the LEAP Study: Feasibility, growth, and nutritionJournal of Allergy and Clinical Immunology, 2016
- Natural history of peanut allergy and predictors of resolution in the first 4 years of life: A population-based assessmentJournal of Allergy and Clinical Immunology, 2015
- Distribution of peanut protein in the home environmentJournal of Allergy and Clinical Immunology, 2013
- Peanut protein in household dust is related to household peanut consumption and is biologically activeJournal of Allergy and Clinical Immunology, 2013
- Tolerant beekeepers display venom-specific functional IgG4 antibodies in the absence of specific IgEJournal of Allergy and Clinical Immunology, 2013
- Identifying infants at high risk of peanut allergy: The Learning Early About Peanut Allergy (LEAP) screening studyJournal of Allergy and Clinical Immunology, 2013